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measures of true trabecular architecture, we anticipate that similar trends
can be demonstrated with higher resolution computed tomography.
Figure 1. Positioning of (a) compartmental and (b) central regions of
interests according to tibial plateau width.
Table I. Correlation coefﬁcients and t-scores of compartmental vs. central BTX (N=34)
BTX Comp. Central B coeff Upper CI Lower CI P-value T-score P-value
BVTV (%) 33.0 32.2 5.44 7.62 3.27 <0.001 2.60 0.014
BSTV (cm−1) 0.3589 0.3591 4.88 8.67 1.08 0.013 −0.063 0.951
Tr.Sp (mm) 0.4363 0.4352 1.99 3.77 0.21 0.030 0.218 0.829
Tr.Th (mm) 0.2293 0.2227 6.20 9.76 2.65 0.001 2.40 0.022
CX (%) −6.683 −8.741 1.36 2.00 0.72 <0.001 2.91 0.006
281 2D TRABECULAR FREE ENDS AND SEMIQUANTITATIVE
SCLEROTIC SCORES ARE SENSITIVE TO KNEE
OSTEOARTHRITIS SEVERITY
A. Wong1, K.A. Beattie1, J. O’Neil2, P.D. Emond1, J. Duryea3, A. Doan1,
J.D. Adachi1, A. Papaioannou1. 1McMaster University, Hamilton, ON,
CANADA, 2St. Joseph’s Health Care, Hamilton, ON, CANADA, 3Harvard
Medical School, Boston, MA, USA
Purpose: (1) To determine the relationship between 2D radiographic
bone texture (BTX) parameters and semiquantitative sclerosis scores
assessed by a radiologist. (2) To assess how subchondral sclerosis
scores differ with respect to OA severity.
Methods: Fixed-ﬂexion radiographs of OA knees were obtained from se-
vere OA participants recommended for total knee arthroplasty. Kellgren-
Lawrence (KL) scores (0 to 4) as well as scores for medial and lateral
subchondral tibial and femoral sclerosis (0 or 1) were determined by
a radiologist (JO) using the Altman radiographic atlas (2007). Apparent
BTX parameters were computed from digitized radiographs in the sub-
compartmental tibia using an anatomic landmark-guided algorithm previ-
ously described. BTX parameters included: bone volume fraction (BVTV),
bone surface area to total volume (BSTV), trabecular spacing (Tr.Sp),
trabecular thickness (Tr.Th) and connectivity index (CX). Medial minimum
joint space width (mJSW) was evaluated using a semi-automated soft-
ware algorithm.
Subchondral sclerosis scores were summated into a binary measure of
diffuse sclerosis (both tibial and femoral sides, score = 2) and localized
sclerosis (absent or single-sided sclerosis, score 1). Correlations be-
tween area-adjusted BTX parameters and binary sclerosis scores were
assessed using binary logistic regression. Both BTX parameters and
binary sclerosis were correlated with mJSW and KL scores using a
binary logistic and linear regression analysis, respectively. Age, gender
and body mass index (BMI) were used as covariates. Pearson correlation
coefﬁcients and odds ratios (OR) are appropriately reported.
Results: In 34 OA knees (17F, 13M; Age: 66±9 yrs; BMI: 31±6 kg×m−2),
diffuse semiquantitative sclerosis was weakly correlated with an in-
creased number of trabecular free ends (FE) (p = 0.021; OR: 1.04 (1.01,
1.07)) after BMI adjustment but not with other topological or run-length
BTX parameters. More diffuse sclerosis was associated with smaller
mJSW and higher KL scores as shown in Table I. Regression analyses
also revealed a negative correlation between FE number and mJSW after
BMI adjustment, and a positive correlation between FE and KL score.
Table I. Relation between two sclerosis measures and each of mJSW and KL score
Semiquantitative Sclerosis Trabecular Free Ends
mJSW (mm) KL score mJSW (mm) KL score
Pearson’s r N/A N/A −0.469 0.345
Odds Ratio 0.271 9.79 N/A N/A
95%CI (0.119, 0.617) (2.20, 43.60) N/A N/A
P-value 0.002 0.003 0.006 0.045
Conclusions: In the subchondral tibia and femur of severe OA knees,
a higher number of trabecular FE only weakly increased the odds of
developing diffuse sclerosis. However, diffuse sclerosis appeared more
sensitive to measures of disease severity (mJSW and KL score). Like-
wise, mJSW and KL scores remain strong correlates of FE. While the
Altman radiographic atlas is able to identify patients with the presence
or absence of sclerosis, 2D analyses of FE are able to quantify sclerotic
severity in a disease-sensitive manner.
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Purpose: The aim of this study is to verify the clinical effects of Autol-
ogous Platelet Rich Plasma (PRP) injections in severe chondropaties of
the knee.
Methods: This study involved 46 consecutive patients with unilateral
knee pain due to chondropaty (III-IV grade ICRS). The patients were
30 males and 16 females, with a mean age 51 years (min 26, max
71). The patients have previously been treated without success for at
least 6 months with physical reconditioning and conservative medical
treatment (ﬁve intra-articular injections of hyaluronic acid). All the patients
were evaluated at the moment of the enrolling with X-rays weight-bearing
and MRI of the knee. According to Kellgren e Lawrence classiﬁcation of
Osteoarthritis 4 patients were deﬁned grade II, 10 patients grade III and
10 patients grade IV. The treatment was conducted as following. 150mL
of venous blood were collected from a peripheral vein. The platelet gel
production was realized through a double venous blood centrifugation
with Cryofuge 6000i [Heraeus], in order to produce 3 subunits (5ml each)
of Platelet Rich Plasma. The Subunit n.1 was injected the same day of
the production, while subunits n.2 and n.3 were stored at −80ºC. Subunits
n.2 and n.3 were unfreezed at 37ºC and injected respectively at 15 and
30 days after the ﬁrst injections. All the patients underwent a clinical
evaluation at the moment of the enrollment, at 2 and 4 months from the
end of the treatment, following KOOS protocol including Pain, Symptoms
and Function subscales. For the statistical analysis the patients were or-
ganized in 3 groups according to sex, age (22 patients 45 years old and
24 patients >45 years old) and the presence or absence of osteoarthritis
in the involved knee. For the statistical analysis Non-parametric Mann
Whitney test and Paired t-test were used.
Results: At 2 and 4 months f.u. the patients showed improvements in
scores in 3 subscales: the mean Pain subscale scores were 44 (±12)
pre-treatment, 68 (±17) at 2 months f.u., 71 (±19) at 4 months f.u.;
the mean Symptoms subscale scores were 46 (±17) pre treatment, 67
(±19) at 2 months f.u., 69 (±20) at 4 months f.u.; the mean Function
subscale scores were 48 (±13) pre-treatment, 67 (±17) at 2 months f.u.,
70 (±18) at 4 months f.u.. Statistical analysis (Paired t-test) showed the
improvement score in all the 3 subscales but it was more signiﬁcative at
2 months (Pain, Symptoms and Function: p< 0.0005) than at 4 months
(Pain p = 0.016, Symptoms p=0.017, Function p = 0.02). The patients
without osteoarthritis showed better results compared to the patients with
osteoarthritis in all the 3 subscales at 2 and 4 months f.u.: the comparison
between the scores improvement was statistically signiﬁcative (Mann-
Whitney test) in all the 3 subscales at the interval 0−2 months (p< 0.11)
and at interval 2−4 months (p< 0.04). The patients with age 45 years
showed better results compared to the patients with age >45 years in
all the 3 subscales at 2 and 4 months f.u.: the comparison between the
scores improvements was statistically signiﬁcative (Mann-Whitney test)
in all the 3 subscales at interval 0−2 months (p< 0.12), but only in Pain
subscale at interval 2−4 months (p< 0.04). The males showed better
results compared to females in all the 3 subscales at 2 and 4 months f.u.:
the comparison between the scores improvement showed a tendency to
signiﬁcance (Mann-Whitney test) at interval 0−2 months (p< 0.15).
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Conclusions: The intra-articular injections of autologous PRP showed a
reduction of pain, symptoms and a recover articular function in patients
affected by severe chondropaties of the knee. The patients 45 years old,
males, and without osteoarthritis showed a faster clinical improvement.
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REPLACEMENT FOR OA – A PROSPECTIVE STUDY
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Purpose: To investigate prospectively the patient-relevant outcome
7 years after total hip replacement (THR) for osteoarthritis (OA).
Methods: 219 consecutive patients (120 women) with primary OA, mean
age 71 (range 50−92) were assigned for THR at the Department of
Orthopedics at Halmstad Central Hospital, Sweden. They were examined
preoperatively, at 3, 6, 12 months, and at 4, 5 and 7 years postoper-
atively with the self-administered questionnaires SF-36 and WOMAC.
Supplementary questions regarding postoperative complications, general
co-morbidity, social circumstances and patient satisfaction were asked
at the three last follow-ups. A matched reference group, 117 subjects
(67 women), mean age 72 (range 52−92) without hip complaints were
recruited from the community and investigated at the same times.
Results: 151/170 (89%) of the patients and 65/74 (88%) of the reference
group participated at the 7 year follow-up. The best postoperative result
was reported one year postoperatively. At that time the only difference
between the two groups was seen in SF-36 physical function (PF), where
the patients scored worse than the reference group (54 vs. 69). At the
later follow-ups there was a successive decline in SF-36 PF compared
to the reference group. However, patients did not report worse WOMAC
function than the reference group. There was no difference in frequency
of co-morbid conditions (19% vs. 31% p< 0.08) between those operated
and the reference group, but those operated were in greater need of
walking aid (46% vs.8% p< 0.0001) and reported more regional pain and
widespread pain (68% vs. 53% p< 0.05). However, 97% of the patients
were satisﬁed with pain relief and 96% with improved physical function
at the 7 year follow-up.
Conclusions: Total hip replacement for osteoarthritis is a successful
procedure. This study shows that in an unselected cohort the patients
experience the same health-related quality of life as a matched reference
group 7 years after THR except for physical function where the patients
score worse. This may be explained by musculoskeletal co-morbidities
such as progress in generalized OA. The difference in outcome between
SF-36 PF and WOMAC function may be explained by the disparity
between a generic and a disease and extremity speciﬁc measurement
where SF-36 PF represents the entire physical function.
284 AN ORAL RECOMBINANT FORM OF SALMON CALCITONIN
SUPPRESSES BOTH BONE RESORPTION AND CARTILAGE
DEGRADATION
I. Byrjalsen, K. Henriksen, B.J. Riis, M.A. Karsdal, C. Christiansen.
Nordic Bioscience, Herlev, DENMARK
Purpose: Calcitonin suppresses bone resorption, and appears to have
an effect on cartilage degradation, and therefore has been speculated to
be useful for treatment of osteoarthritis. However, the pharmacodynamic
proﬁle of sCT on cartilage degradation is not clear. The aim of the study
was to assess the effect of bi-daily dosing with 0.8mg of oral salmon
calcitonin (sCT) given in the morning at 08:00 and pre-dinner at 17:00
with respect to reduction of both bone resorption (CTX-I) and cartilage
degradation (CTX-II).
Methods: Participants were from a randomized, double-blind, placebo-
controlled 14-day treatment study including postmenopausal women and
men (n=73) suffering from osteoarthritis (OA). One of the treatment arms
comprised administration of 0.8mg of oral sCT given twice daily with one
dose given in the morning to fasting individuals at 08:00, and one dose
given pre-dinner at 17:00 (n=26). On treatment day 1 and day 14, blood
samples were taken before drug intake, and at 10, 15, 30, 45 minutes,
and 1, 2, and 4 hours for plasma sCT measurements. Urine samples were
collected at baseline, at 2, 4, 6, 8, 11 and 13 hours. The absorption of
calcitonin was assessed by measurement of plasma sCT concentrations,
and bone resorption by the biochemical marker of urine CTX-I (C-terminal
telopeptide of collagen type I). Cartilage degradation was assessed by
urine CTX-II (C-terminal telopeptide of collagen type II).
Results: Dosing with oral sCT resulted in a signiﬁcant increase in
plasma sCT levels, which was eliminated within two hours after dosing. In
alignment, urine CTX-I was suppressed over placebo with an AUC0−8hrs of
−425 [%×Hrs] at the 8:00 dose compared to −105 [%Hrs] in the placebo
group (p = 0.003). The suppression of CTX-I was present throughout the
13 hours sampling period. For CTX-II a suppression of the AUC0−8hrs
of −355 [%Hrs] was observed compared to −60 [%Hrs] in the placebo
group (p< 0.007). The suppression of CTX-II was not alleviated within
the 13 hour observation period. The results from the day 14 analysis
were all in the same magnitude.
Conclusions: We found that an oral recombinant form of salmon calci-
tonin signiﬁcantly suppressed both bone resorption and cartilage degra-
dation within a short time span. These studies warrant further investiga-
tion of the potential use of oral calcitonin for treatment of osteoarthritis.
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Purpose: EOA is believed to be a clinical subset of OA most often
involving the hands of middle-aged women and characterised by a
frequent aggressive clinical course. In EOA, pain and inﬂammation persist
or recur for many years, in contrast with the more common nodal OA
(non-EOA), in which they are usually found only at the disease onset.
Despite its severity, EOA is still poorly deﬁned, so it is debated whether
or not it belongs to OA or is a separate entity. Since very few reports are
available concerning the various features of EOA, the aim of our study
was to analyse its clinical, radiological and immunogenetic aspects in a
cohort of 109 patients observed in our unit, and compare these with a
series of non-EOA patients
Methods: A total of 162 patients, 109 with EOA and 53 with non-EOA
were analysed. All patients satisﬁed the Altman criteria for OA of the hand.
Patients showing at least two erosions in interphalangeal (IP) joints were
included in EOA, while patients with erosions in metacarpophalangeal
joints were excluded. In all patients (EOA and non-EOA) we evaluated
the number of active joints (AJ) (swollen and painful), number of joints
involved (NJI) and the radiographic score (RS) by Kallman scale. In
24 patients with EOA followed for at least two years, we evaluated the
outcome for clinical and radiological aspects. Patients underwent hand
X-rays at the baseline and after a two year period and assessment was
done by two experienced operators. The clinical examination was also
performed at the ﬁrst visit and after two years. In all patients HLA typing
was determinated on blood samples (GenoPrepTM DNA from Blood Kit
by GenoVision A.S, Norway; PCR Master Mixes).
Results: No difference was observed between EOA and non-EOA for age
and disease duration. The mean number of erosions in EOA was 4.01
(±2.4). Both the number of AJ and the RS were higher in EOA (6.3±2.4
and 65.9±26.5, respectively) than in non-EOA (4.5±4.6, p = 0.02 and
32.1±19.1, p< 0.001, respectively).
In the subset of 24 patients with highest RS at baseline and more severe
joint involvement, we observed a signiﬁcant worsening in both radiological
and clinical parameters (RS at baseline vs two years p< 0.001; NJI vs
NJI2 p< 0.001; AJ vs AJ2 p< 0.012). Concerning HLA, in this subgroup
of patients we observed higher frequency of the allele A24 (29.1%), A2
(45.8%), DRB1 11 (37.5%), DRB 07 (16.6%).
Conclusions: EOA clearly differs from non-EOA in many aspects, in-
cluding the higher AJ and RS, so conﬁrming its severity. We observed a
more aggressive clinical course in the subgroup of patients who presented
higher scores at the ﬁrst visit. The association with some HLA alleles, in
particular A2, A24, DRB 07 and 11, suggests a more severe subset of
patients. Further studies are needed to conﬁrm these data.
286 DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS (DISH) AT,
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R. Mader1, I. Lavi2. 1Ha’Emek Medical Center, Afula, ISRAEL, 2Carmel
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Purpose: At present, the diagnosis of DISH is based on characteristic
ﬁnding in radiographs of the thoracic spine, which are not often ordered.
